# Fifty‐two week follow‐up safety and effectiveness results of dupilumab treatment of moderate‐to‐severe atopic dermatitis from a retrospective, multicentric series

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/fifty-two-week-follow-up-safety-and-effectiveness-results-of-dupilumab-treatment/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ricardo Ruíz‐Villaverde,J.J. Domínguez-Cruz,José Carlos Armario Hita,L. Martínez-Pilar,Sara Alcantara‐Luna,Jose Juan Pereyra‐Rodriguez |
| Citations | 29 |
| DOI | 10.1111/dth.12931 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2936645347 |
| PMID | 30980485 |
| Type | article |
| Year | 2019 |

## Paper authors

- [J.J. Domínguez-Cruz](https://scholariq.org/researchers/j-j-dominguez-cruz/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Urticaria and Related Conditions](https://scholariq.org/topics/urticaria-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.